Coreopsis tinctoria buds polysaccharides boost metformin's antihyperglycemic effect in diabetic mice via gut microbiota and metabolism modulation
Coreopsis tinctoria bud is a characteristic plant of Xinjiang Uygur Autonomous Region, and it has various biological activities.This study investigated the effects of low-dose metformin (LMET) and the sodium hydroxide extract of Coreopsis tinctoria buds polysaccharides (Al) on streptozotocin-induced diabetes. The aim was to explore the potential mechanisms of LMET+Al and metformin alone in treating diabetes. The results showed that both metformin and LMET+Al could reduce weight loss and improve hyperglycemia in mice. Specifically, LMET+Al effectively lowered fasting blood glucose, enhanced glucose tolerance, promoted glycogen synthesis, improved islet function, and stimulated insulin secretion. It also better prevented islet cell atrophy by inhibiting cleaved Caspase-3 and the inflammatory factor NLRP-3. Gut microbiota analysis revealed higher levels of the probiotic Ligilactobacillus in the LMET+Al group compared to the metformin group. Metabolite analysis indicated that LMET+Al regulated diabetic mice through pathways like Aspartate Metabolism and Sphingolipid Metabolism. Correlation analysis showed that gut microbiota and metabolites were closely linked, with sphingosine positively correlated with Muribaculum and Alistipes_A ( p < 0.05) and negatively correlated with Acinetobacter ( p < 0.05). These interactions collectively contributed to host health. The findings suggest that Al may serve as a useful adjunct hypoglycemic agent for metformin in future applications. • The hypoglycemic effect of the combined application of Lose-dose Al and metformin is better than that of metformin alone. • Lose-dose Al and metformin protectd pancreatic tissue by reducing damage and suppressing cleaved Caspase-3/NLRP-3 expression. • Lose-dose Al and metformin modulatedgut microbiota, notably increasing beneficial Ligilactobacillus abundance. • Lose-dose Al and metformin improved metabolic disorders and demonstrates potential as a natural anti-diabetic agent.
Authors
- Yijiao Sun (ORCID: https://orcid.org/0000-0001-8491-0957)
- Yang Wang (ORCID: https://orcid.org/0000-0003-2809-2827)
- Jun Ruan
- Deyan Zhu
- Yufeng Li
- Rong Li
Institutions
- First People’s Hospital of Jingmen (CN)
- Jingchu University of Technology (CN)
- Anhui Polytechnic University (CN)
Publication Details
- Journal
- Industrial Crops and Products
- Published
- 2026-01-13
- DOI
- https://doi.org/10.1016/j.indcrop.2025.122574
- Primary Topic
- Metabolism, Diabetes, and Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00